SemaglutideQualityChecker
Semaglutide
Semaglutide Quality Checker — GLP-1 Agonist (Ph. Eur., USP)
ℹ️ The utility checks assay, lipidation degree, desacyl impurity, aggregates, methionine oxidation.
ℹ️ Does not use machine learning — rule-based logic only.
️ CRITICAL! Lipidation degree ≥95%. Desacyl impurity ≤1.0%. Aggregates ≤1.0%!
Usage:
SemaglutideQualityChecker.exe → demo mode
SemaglutideQualityChecker.exe input.csv output.json → evaluate data
Input format:
BatchNumber,Assay_Percent,Lipidation_Degree_Percent,Deletion_Impurity_Percent,Insertion_Impurity_Percent,Oxidized_Impurity_Percent,Deamidated_Impurity_Percent,Desacyl_Impurity_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Residual_Solvent_Acetonitrile_ppm,Residual_Solvent_TFA_ppm,Heavy_Metals_ppm,Sulfated_Ash_Percent,Aggregate_Percent_SEC,Dissolution_30min_Percent,Dissolution_60min_Percent,Weight_Variation_RSD,Friability_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected
Example:
SEM-SUB-2026-001,99.2,98.5,0.4,0.2,0.3,0.25,0.5,1.7,3.5,150,200,4,0.08,0.4,0.0,0.0,0.0,0.0,15,4,0,0
— WHY IS THIS NEEDED?
Semaglutide — long-chain peptide GLP-1 agonist with attached fatty acid (C-18):
• Lipidation: Key parameter. Fatty acid is required for albumin binding and extended half-life. Insufficient lipidation (<95%) renders the drug ineffective (rapid clearance).
• Desacyl Impurity: Peptide without fatty acid. Critical impurity as it lacks prolonged action. Strict limit (≤1.0%).
• Peptide Impurities: Synthesis defects lead to deletions or insertions of amino acids. Methionine oxidation reduces activity.
• Aggregates: Peptides are prone to aggregation, increasing immunogenicity risk (antibody formation). Limit ≤1.0%.
• Residual Solvents: Solid-phase synthesis often uses acetonitrile and trifluoroacetic acid (TFA). TFA control is specific to peptides.
⚠️ CRITICAL:
• Assay: 95–105%
• Lipidation Degree: 95–102% (Critical!)
• Desacyl Impurity: ≤ 1.0%
• Deletion Impurities: ≤ 1.0%
• Oxidized Impurities (Met): ≤ 1.0%
• Total Impurities: ≤ 2.0%
• Aggregates: ≤ 1.0%
• Acetonitrile: ≤ 410 ppm
• TFA: ≤ 500 ppm
• Heavy Metals: ≤ 10 ppm
• Dissolution: ≥ 80% in 30 min, ≥ 85% in 60 min
• Microbiology: standard limits
⚠️ Note: Utility adapted for lipidated peptide specifics. If dissolution data absent (0), check skipped (for substance). For finished forms, deviation from dissolution profile is critical defect. Control of lipidation degree and desacyl form is an absolute efficacy priority.
input.csv
BatchNumber,Assay_Percent,Lipidation_Degree_Percent,Deletion_Impurity_Percent,Insertion_Impurity_Percent,Oxidized_Impurity_Percent,Deamidated_Impurity_Percent,Desacyl_Impurity_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Residual_Solvent_Acetonitrile_ppm,Residual_Solvent_TFA_ppm,Heavy_Metals_ppm,Sulfated_Ash_Percent,Aggregate_Percent_SEC,Dissolution_30min_Percent,Dissolution_60min_Percent,Weight_Variation_RSD,Friability_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected SEM-SUB-2026-001,99.2,98.5,0.4,0.2,0.3,0.25,0.5,1.7,3.5,150,200,4,0.08,0.4,0.0,0.0,0.0,0.0,15,4,0,0
URS & FS — user requirements and functional specification
This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.
1. Scope
The Semaglutide Quality Checker utility is used for Semaglutide. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.
The utility does not use machine learning; decisions are produced by deterministic rules.
Categories: Global API expansion
Tags: antivirals, API, biologics, dissolution, essential medicines, global market, heavy metals, impurities, microbiology, oncology, residual solvents
2. Execution modes
SemaglutideQualityChecker.exe → demo mode SemaglutideQualityChecker.exe input.csv output.json → evaluate data
3. Key controlled areas
- assay / content
- purity and impurities
- dissolution / disintegration
- residual solvents
- microbiology and pathogens
- heavy metals / elemental impurities
4. Domain limits and critical parameters
- Lipidation: Key parameter. Fatty acid is required for albumin binding and extended half-life. Insufficient lipidation (<95%) renders the drug ineffective (rapid clearance).
- Desacyl Impurity: Peptide without fatty acid. Critical impurity as it lacks prolonged action. Strict limit (≤1.0%).
- Aggregates: Peptides are prone to aggregation, increasing immunogenicity risk (antibody formation). Limit ≤1.0%.
- ⚠️ CRITICAL:
- Assay: 95–105%
- Lipidation Degree: 95–102% (Critical!)
- Desacyl Impurity: ≤ 1.0%
- Deletion Impurities: ≤ 1.0%
- Oxidized Impurities (Met): ≤ 1.0%
- Total Impurities: ≤ 2.0%
- Aggregates: ≤ 1.0%
- Acetonitrile: ≤ 410 ppm
- TFA: ≤ 500 ppm
- Heavy Metals: ≤ 10 ppm
- Dissolution: ≥ 80% in 30 min, ≥ 85% in 60 min
- Microbiology: standard limits
- ⚠️ Note: Utility adapted for lipidated peptide specifics. If dissolution data absent (0), check skipped (for substance). For finished forms, deviation from dissolution profile is critical defect. Control of lipidation degree and desacyl form is an absolute efficacy priority.
5. URS — user requirements
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The system shall accept an input.csv file for Semaglutide with the exact columns listed in the “Input data contract” section. | High | A file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error. |
| URS-002 | The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data. | Medium | Both execution scenarios produce a predictable result or clear diagnostic error. |
| URS-003 | The system shall perform rule-based controls for: assay / content, purity and impurities, dissolution / disintegration, residual solvents, microbiology and pathogens, heavy metals / elemental impurities. | High | Each controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML. |
| URS-004 | The system shall preserve traceability between batch/lot, source values, applied rules and final verdict. | High | Output includes batch identifier, source values, parameter statuses and critical findings. |
| URS-005 | The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review. | High | JSON contains overall status, check array, warnings, failures and source-file reference. |
| URS-006 | The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks. | High | The document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval. |
| URS-007 | The system shall clearly separate technical data errors from specification nonconformities. | Medium | Schema/type errors are not mixed with pharmacopoeial deviations and are reported separately. |
6. input.csv data contract
The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.
| # | Column | Type | Unit | Description | Sample | Control rule |
|---|---|---|---|---|---|---|
| 1 | BatchNumber | identifier | as specified | Batch Number | SEM-SUB-2026-001 | mandatory field; used for batch/lot traceability |
| 2 | Assay_Percent | decimal | % | Assay % | 99.2 | numeric value; compared with assay/purity limit from specification or method |
| 3 | Lipidation_Degree_Percent | decimal | % | Lipidation Degree % | 98.5 | mandatory numeric value; rule comparison is performed by the utility |
| 4 | Deletion_Impurity_Percent | decimal | % | Deletion Impurity % | 0.4 | numeric value; compared with individual or total impurity limit |
| 5 | Insertion_Impurity_Percent | decimal | % | Insertion Impurity % | 0.2 | numeric value; compared with individual or total impurity limit |
| 6 | Oxidized_Impurity_Percent | decimal | % | Oxidized Impurity % | 0.3 | numeric value; compared with individual or total impurity limit |
| 7 | Deamidated_Impurity_Percent | date/time | % | Deamidated Impurity % | 0.25 | numeric value; compared with individual or total impurity limit |
| 8 | Desacyl_Impurity_Percent | decimal | % | Desacyl Impurity % | 0.5 | numeric value; compared with individual or total impurity limit |
| 9 | Total_Impurities_Percent | decimal | % | Total Impurities % | 1.7 | mandatory numeric value; rule comparison is performed by the utility |
| 10 | Loss_On_Drying_Percent | decimal | % | Loss On Drying % | 3.5 | mandatory numeric value; rule comparison is performed by the utility |
| 11 | Residual_Solvent_Acetonitrile_ppm | decimal | ppm | Residual Solvent Acetonitrile ppm | 150 | numeric value; checked as residual solvent against the applicable limit |
| 12 | Residual_Solvent_TFA_ppm | decimal | ppm | Residual Solvent TFA ppm | 200 | numeric value; checked as residual solvent against the applicable limit |
| 13 | Heavy_Metals_ppm | decimal | ppm | Heavy Metals ppm | 4 | numeric value; checked as elemental/metal impurity |
| 14 | Sulfated_Ash_Percent | decimal | % | Sulfated Ash % | 0.08 | mandatory numeric value; rule comparison is performed by the utility |
| 15 | Aggregate_Percent_SEC | decimal | % | Aggregate % SEC | 0.4 | mandatory numeric value; rule comparison is performed by the utility |
| 16 | Dissolution_30min_Percent | decimal | % | Dissolution 30min % | 0.0 | numeric value; dissolution/disintegration profile checked according to method |
| 17 | Dissolution_60min_Percent | decimal | % | Dissolution 60min % | 0.0 | numeric value; dissolution/disintegration profile checked according to method |
| 18 | Weight_Variation_RSD | decimal | as specified | Weight Variation RSD | 0.0 | mandatory numeric value; rule comparison is performed by the utility |
| 19 | Friability_Percent | decimal | % | Friability % | 0.0 | mandatory numeric value; rule comparison is performed by the utility |
| 20 | Microbial_Count_TAMC | decimal | as specified | Microbial Count TAMC | 15 | numeric value; compared with microbiological limits |
| 21 | Microbial_Count_TYMC | decimal | as specified | Microbial Count TYMC | 4 | numeric value; compared with microbiological limits |
| 22 | EColi_Detected | boolean / flag | 0/1 | EColi Detected | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
| 23 | Salmonella_Detected | boolean / flag | 0/1 | Salmonella Detected | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
CSV example
BatchNumber,Assay_Percent,Lipidation_Degree_Percent,Deletion_Impurity_Percent,Insertion_Impurity_Percent,Oxidized_Impurity_Percent,Deamidated_Impurity_Percent,Desacyl_Impurity_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Residual_Solvent_Acetonitrile_ppm,Residual_Solvent_TFA_ppm,Heavy_Metals_ppm,Sulfated_Ash_Percent,Aggregate_Percent_SEC,Dissolution_30min_Percent,Dissolution_60min_Percent,Weight_Variation_RSD,Friability_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected SEM-SUB-2026-001,99.2,98.5,0.4,0.2,0.3,0.25,0.5,1.7,3.5,150,200,4,0.08,0.4,0.0,0.0,0.0,0.0,15,4,0,0
7. FS — functional specification
| ID | Function | Implementation description |
|---|---|---|
| FS-001 | CLI entry point | The executable SemaglutideQualityChecker.exe supports demo mode and input.csv output.json processing mode. |
| FS-002 | CSV parser | The import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator. |
| FS-003 | Field conversion | Each column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag. |
| FS-004 | Domain rule engine | For Semaglutide, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check. |
| FS-005 | Criticality handling | Critical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS. |
| FS-006 | JSON writer | output.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages. |
| FS-007 | Integration contract | The CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service. |
| FS-008 | Error handling | Schema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS. |
8. output.json contract
The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.
{
"utility": "SemaglutideQualityChecker",
"api": "Semaglutide",
"batchNumber": "SEM-SUB-2026-001",
"overallStatus": "PASS|WARNING|FAIL",
"checkedAtUtc": "2026-05-18T00:00:00Z",
"checks": [
{
"parameter": "BatchNumber",
"value": "SEM-SUB-2026-001",
"unit": "as specified",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Assay_Percent",
"value": "99.2",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Lipidation_Degree_Percent",
"value": "98.5",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Deletion_Impurity_Percent",
"value": "0.4",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Insertion_Impurity_Percent",
"value": "0.2",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Oxidized_Impurity_Percent",
"value": "0.3",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Deamidated_Impurity_Percent",
"value": "0.25",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Desacyl_Impurity_Percent",
"value": "0.5",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": [],
"sourceFile": "input.csv"
}9. OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| TC-001 | Valid CSV with expected header and sample row | All rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail. |
| TC-002 | A mandatory input.csv column is missing | Import is rejected or the row receives FAIL with schema reference. |
| TC-003 | A numeric field contains text or a blank value | Type conversion error is recorded; the result is not hidden as PASS. |
| TC-004 | A parameter is outside specification or critical limit | Critical parameters produce FAIL; non-critical deviations produce WARNING according to the rule. |
| TC-005 | Positive pathogen/microbiological flag or microbiological limit excursion | Critical FAIL is produced with the offending parameter. |
| TC-006 | Insufficient dissolution or excessive disintegration time | FAIL/WARNING is produced according to method criticality. |
| TC-007 | Residual solvent above applicable limit | FAIL is produced with solvent name and measured value. |
10. QA/QC, CSV and change control
- Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
- Column names must not be changed without updating the validator and test scenarios.
- The source CSV, output.json and utility version should be stored together as an evidence package.
- Any change in control rules must go through change control and repeated OQ scenario verification.
Included in packages
Algeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenArgentina: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenAustralia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenBangladesh: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenBrazil: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenCanada: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenCardiology QC Suite
QC package for cardiology medicines: antihypertensives, anticoagulants, antiplatelets, lipid-lowering and antiarrhythmic medicines plus supporting QC checks.
OpenChina: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenColombia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenDemocratic Republic of the Congo: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenDiabetes QC Suite
QC package for diabetes medicines: insulins, metformin, SGLT2/DPP-4/GLP-1 products, glucagon and supporting dosage-form quality checks.
OpenEgypt: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenEthiopia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenFrance: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenGermany: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenIndia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenIndonesia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenIran: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenItaly: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenJapan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenKenya: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenMexico: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenMyanmar: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenNigeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenPakistan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenPhilippines: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenRussia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSaudi Arabia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSouth Africa: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSouth Korea: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSudan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenTanzania: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenThailand: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenTurkey: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUganda: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited Kingdom: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited States: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenVietnam: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenWorld API Extension QC Suite
Extended package for 130 additional high-demand APIs and biological products prepared as a market-coverage backlog.
Open